Table 2. Daily Dietary Fatty Acid Consumption and Clinical Profile in Participants With and Without Glaucoma.
| Variable | Median (SE) | P Value | |
|---|---|---|---|
| With Glaucoma | Without Glaucoma | ||
| Saturated fatty acid, g | 23.60 (0.98) | 26.94 (0.39) | .003 |
| Monounsaturated fatty acid, g | 27.52 (1.24) | 30.05 (0.41) | .07 |
| Polyunsaturated fatty acid, g | 17.22 (1.02) | 17.67 (0.22) | .67 |
| Total cholesterol, mg/dL | 198.25 (3.55) | 205.46 (0.82) | .051 |
| High-density lipoprotein cholesterol, mg/dL | 54.40 (1.74) | 53.82 (0.41) | .73 |
| Low-density lipoprotein cholesterol, mg/dL | 113.20 (4.10) | 121.10 (1.07) | .06 |
| Triglycerides, mg/dL | 146.30 (10.85) | 148.52 (3.72) | .87 |
| Octadecadienoic acid (PUFA 18:2), ga | 13.21 (0.77) | 13.85 (0.21) | .76 |
| Octadecatrienoic acid (PUFA 18:3), g | 1.25 (0.058) | 1.34 (0.016) | .26 |
| Octadecatetraenoic acid (PUFA 18:4), mg | 0 (0.33) | 0.26 (0.040) | .01 |
| Eicosatetraenoic acid (PUFA 20:4), mg | 11.0 (6.5) | 12.0 (2.3) | .54 |
| Eicosapentaenoic acid (PUFA 20:5), mg | 8.54 (1.2) | 8.50 (0.55) | .002 |
| Docosapentaenoic acid (PUFA 22:5), mg | 11.0 (1.4) | 9.2 (0.5) | .02 |
| Docosahexaenoic acid (PUFA 22:6), mg | 34.4 (6.3) | 33.8 (1.3) | .04 |
Abbreviation: PUFA, polyunsaturated fatty acid.
SI conversion factors: To convert total, high-density lipoprotein, and low-density lipoprotein cholesterol levels to millimoles per liter, multiply values by 0.0259; serum triglyceride level to millimoles per liter, by 0.0113.
a
For an explanation of PUFA entries, see the Figure and its legend.